Presently, Dana Pizzuti occupies the position of Chief Medical Officer at Ascendis Pharma A.
In her past career she was Vice President-Global Regulatory Affairs at Johnson & Johnson, SVP-Regulatory Affairs & Quality at Rigel Pharmaceuticals, Inc., SVP-Regulatory Affairs & Quality at Theravance Biopharma, Inc., Vice President-Regulatory Affairs of Gilead Sciences, Inc. and Vice President-Global Pharmacovigilance & Labeling at Bristol-Myers Squibb AB.
Dana Pizzuti received a doctorate from New York University and an undergraduate degree from Yale University.
|